Literature DB >> 6989911

In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cells.

M T Lotze, J L Strausser, S A Rosenberg.   

Abstract

Soft agar and limiting dilution techniques utilizing human T cell growth factor (TCGF) have been developed to clone human lymphoid cells with high cloning efficiency. TCGF has been used for the continued growth and expansion of lymphoid populations derived from single T cells, and the cytotoxic specificity of individual clones has been repeatedly examined. An analysis of clones derived from human lymphocytes sensitized to allogeneic determinants in vitro reveals significant polymorphism in lytic recognition when tested against HLA typed targets. This pattern of reactivity remained constant over the 2 months of continuous culture. These methods should be capable of dissecting and analyzing the fine specificity of the T cell response.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6989911

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Transferrin receptor: its biological significance.

Authors:  W S May; P Cuatrecasas
Journal:  J Membr Biol       Date:  1985       Impact factor: 1.843

2.  Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures.

Authors:  P Hersey; M MacDonald; S Schibeci; C Burns
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 3.  IL-2: the first effective immunotherapy for human cancer.

Authors:  Steven A Rosenberg
Journal:  J Immunol       Date:  2014-06-15       Impact factor: 5.422

4.  Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.

Authors:  T Yamasaki; H Handa; J Yamashita; Y Watanabe; Y Namba; M Hanaoka
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

5.  HLA-DR antigens induce proliferation and cytotoxicity of T cells against haptenated (TNP and FITC) self structures.

Authors:  R Palacios; G Möller; L Claesson; P A Peterson
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

6.  Human spleen as a source of T cell growth factor.

Authors:  A Moretta; M Colombatti; B Chapuis
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

7.  Antigen-specific human T-cell clones: development of clones requiring HLA-DR-compatible presenting cells for stimulation in presence of antigen.

Authors:  B Sredni; D Volkman; R H Schwartz; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

8.  Human T-cell cultures with selective autotumor reactivity.

Authors:  F Vánky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

9.  Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF).

Authors:  E Kedar; B L Ikejiri; E Gorelik; R B Herbermann
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

10.  Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function.

Authors:  T B Nutman; E A Ottesen; A S Fauci; D J Volkman
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.